InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,735.09
(
-0.05%
)
US TECH 100
19,398.80
(
-0.37%
)
Dow Jones
42,260.15
(
-0.12%
)
Brent Oil
71.66
(
-0.07%
)
Bitcoin
63,949.77
(
-2.56%
)
Post# of 470474
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

WolfofMia

Send PM Follow Ignore
Followers 19
Posts 4619
Boards Moderated 0
Alias Born 04/12/2017

WolfofMia

Re: Investor2014 post# 226482

Wednesday, 12/25/2019 6:48:01 PM

Wednesday, December 25, 2019 6:48:01 PM

Post# of 470474

Yes because they would know there are several S1R agonists on the market compared to which A2-73 underperforms and therefore there is absolutely no reason to invest in $AVXL.



Man this biotech stuff is hard, specially the whole SR1 agonist thing.

Here I thought we had the best "agonist" ;)
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!